Please read this carefully. It defines what GLP Notes is and, just as importantly, what it is not.
Informational only — not medical advice
GLP Notes publishes general educational information about GLP-1 receptor agonist medications. It is not medical advice, it is not a substitute for professional care, and it is not tailored to your situation. Reading this site does not create a clinician-patient relationship between you and GLP Notes or any reviewer.
Always talk to a licensed clinician before starting, stopping, or changing any medication, and follow your own prescriber's instructions over anything you read here.
No dosing prescriptions
Where we describe titration schedules or doses, we present them as typical, prescriber-directed reference information — never as a prescription or an instruction to self-administer. We publish no self-dosing protocols. Dosing decisions belong to you and your prescriber.
Emergencies
GLP Notes cannot help in an emergency. If you have severe or alarming symptoms, seek care immediately — contact your clinician, an urgent-care service, or your local emergency number. See when to seek emergency care for the red-flag symptoms that warrant urgent attention.
Accuracy and updates
We work hard to keep pages accurate and current, and we date our reviews, but medicine changes and errors are possible. We make no warranty that any page is complete or current, and we are not liable for decisions made based on this information.
Trademarks
Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, Trulicity, and other product names are trademarks of their respective owners and are used here only nominatively to identify the medications discussed. Their use does not imply any affiliation with or endorsement by the trademark holders.
Every clinical claim above is cited inline to a primary source. See how we review and our sourcing & fact-check standards.